Cabaletta Bio (CABA) Interest Expenses (2018 - 2025)
Cabaletta Bio's (CABA) quarterly Interest Expenses came in at -$4.3 million in Q4 2025, down 672.59% year-on-year from $748000.0 in Q4 2024, and down 119.33% quarter-over-quarter from $22.2 million in Q3 2025.
Cabaletta Bio (CABA) Interest Expenses (2018 - 2025) Analysis & Trends
Cabaletta Bio's Interest Expenses history runs 8 years deep, the most recent figure standing at -$4.3 million for Q4 2025.
- On a quarterly basis, Interest Expenses fell 672.59% year-over-year to -$4.3 million in Q4 2025; TTM through Dec 2025 was -$834000.0, a 124.18% decrease from a year earlier, with the FY2025 full-year figure at $157.8 million, up 42.56% from the prior year.
- Interest Expenses retreated to -$4.3 million in Q4 2025 per CABA's latest filing, from $22.2 million in the prior quarter.
- Across five years, Interest Expenses topped out at $69.8 million in Q1 2024 and bottomed at -$4.3 million in Q4 2025.
- The 5-year median for Interest Expenses is $10.1 million (2022), against an average of $15.7 million.
- Across the five-year window, Interest Expenses surged 122840.43% in 2022 and slumped 672.59% in 2025, its largest moves.
- Year by year, Interest Expenses stood at $2367.0 in 2021, then jumped by 122840.43% to $2.9 million in 2022, then tumbled by 107.18% to -$209000.0 in 2023, then surged by 457.89% to $748000.0 in 2024, then slumped by 672.59% to -$4.3 million in 2025.
- Per Business Quant, the three latest CABA Interest Expenses figures stand at -$4.3 million (Q4 2025), $22.2 million (Q3 2025), and $4.6 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Cabaletta Bio | 182.04 Mn | 182.04 Mn | - | -4.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.28 Mn |
| Dec 31, 2025 | -4.28 Mn |
| Sep 30, 2025 | 22.15 Mn |
| Sep 30, 2025 | 22.15 Mn |
| Jun 30, 2025 | 4.57 Mn |
| Jun 30, 2025 | 4.57 Mn |
| Mar 31, 2025 | 5.48 Mn |
| Mar 31, 2025 | 5.48 Mn |
| Dec 31, 2024 | 748,000.00 |
| Dec 31, 2024 | 748,000.00 |
| Sep 30, 2024 | 15.22 Mn |
| Sep 30, 2024 | 15.22 Mn |
| Jun 30, 2024 | 13.43 Mn |
| Jun 30, 2024 | 13.43 Mn |
| Mar 31, 2024 | 69.77 Mn |
| Mar 31, 2024 | 69.77 Mn |
| Dec 31, 2023 | -209,000.00 |
| Dec 31, 2023 | -209,000.00 |
| Sep 30, 2023 | 58.88 Mn |
| Sep 30, 2023 | 58.88 Mn |